The PRIORITY Study in Cervical Cancer: A Prospective Multicenter Observational Evaluation of an Integrated Molecular and Digital Model for Diagnostic Prioritization
Sponsor: Pontificia Universidad Catolica de Chile
Trial Details
| Condition | Cervical Cancer, Cervical Intraepithelial Neoplasia, HPV Infection |
| Status | Not_yet_recruiting |
| Participants | 700 |
| Est. Completion | 31 Dec 2026 |
| Last Updated | 18 May 2026 |
Primary Outcome
Diagnostic accuracy of the integrated molecular and digital model for detection of CIN2+
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Women aged 30 to 65 years * Eligible for cervical cancer screening according to national guidelines * Able and willing to provide informed consent * Able to perform self-sampling or attend clinical evaluation if required Exclusion Criteria: * Previous diagnosis of cervical cancer * History of total hysterectomy (removal of the cervix) * Current pregnancy if it precludes study procedures according to clinical judgment * Any medical or social condition that, in the opinion of the investigators, would interfere with participation or follow-up
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service